Acurx Pharmaceuticals (ACXP) Assets (2020 - 2026)
Acurx Pharmaceuticals (ACXP) reported Assets of $10.98 million for Q2 2026, up 78.4% from $6.16 million a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Acurx Pharmaceuticals posted Assets of $7.69 million, up 99.3% from FY2024.
- Assets has a five-year compound annual growth rate of 19.0% (FY2020 to FY2025).
- By year, Assets came in at $3.86 million in FY2024 (-50.0%), $7.71 million in FY2023 (-17.8%), $9.38 million in FY2022 (-29.3%) and $13.25 million in FY2021 (+311.1%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q1 2022.
- Year over year, Assets has now increased in each of the last four quarters, with growth averaging 19.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 311.1%); the low point was Q4 2024 (a decline of 50.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.54 million (Q1 2026), $7.69 million (Q4 2025) and $6.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Acurx Pharmaceuticals | 4.86 Mn | -28.61 Mn | - | 10.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.98 Mn |
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 6.58 Mn |
| Mar 31, 2024 | 9.11 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Sep 30, 2023 | 7.16 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 7.39 Mn |
| Dec 31, 2022 | 9.38 Mn |
| Sep 30, 2022 | 10.95 Mn |
| Jun 30, 2022 | 9.26 Mn |
| Mar 31, 2022 | 11.32 Mn |
| Dec 31, 2021 | 13.25 Mn |
| Sep 30, 2021 | 14.99 Mn |
API Access
Acurx Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();